Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Aurobindo Pharma May Acquire Russian Business of Shreya Life Sciences 13
Intas Pharma and Aurobindo Pharma May Acquire Europen Divisions from Teva Pharma 14
Aurobindo Pharma Acquires Four Biosimilar Products from TL Biopharma 15
Arrow Generiques to Acquire Select Commercial Products in France from Teva Pharma 16
Cipla and Aurobindo Acquires Certain Generic Products Rights in the US from Teva Pharma 17
Aurobindo Pharma Completes Acquisition Of Generics Operations Of Actavis In Western Europe For US$40.8 Million 18
Partnerships 20
Aurobindo Pharma Forms Joint Venture with Tergene Biotech 20
Celon Labs Forms Joint Venture with Aurobindo Pharma 21
Aurobindo Pharma Forms Joint Venture With DIODE 22
Licensing Agreements 23
Aurobindo Pharma, Cipla, Desano Pharma, Emcure Pharma, Hetero Labs and Laurus Labs Enter into Licensing Agreement with Medicines Patent Pool 23
Aurobindo Pharma Extends its Licensing Agreement with Medicines Patent Pool 25
Aurobindo Pharma Enters into Licensing Agreement with Medicines Patent Pool 26
Aurobindo Pharma Enters into Licensing Agreement with Medicines Patent Pool for Lopinavir/Ritonavir 27
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 28
Equity Offering 30
Aurobindo Pharma Plans to Raise USD300 Million in Private Placement of Shares 30
Aurobindo Pharma Receives Board Approval for Private Placement of Shares for up to USD350 Million 31
Asset Transactions 32
Aurobindo Pharma Sells Manufacturing Facility In Tamilnadu 32
Acquisition 33
Aurobindo Pharma to Acquire Additional 20% Stake in Tergene Biotech 33
Agile Pharma Acquires Generis Farmaceutica from Magnum Capital Partners for USD142.8 Million 34
Eris Pharma Acquires Aurobindo Pharma Australia from Aurobindo Pharma 35
Aurobindo Pharma Acquires Natrol for USD132.5 Million 36
Aurobindo Pharma Acquires Hyacinths Pharma for up to USD3 Million 37
Aurobindo Pharma Acquires Remaining 25% Stake in Silicon Life Sciences from ABS Mercantiles 38
Aurobindo Pharma To Acquire Branded Formulations Marketing Company 39
China National Pharma Completes Acquisition Of 80.5% Interest In Aurobindo (Datong) Bio Pharma 40
Aurbindo Pharma Sells 50% Stake In Cephazone Pharma, Maker Of Cephalosporin Products 41
Aurobindo Pharma Ltd – Key Competitors 42
Aurobindo Pharma Ltd – Key Employees 43
Aurobindo Pharma Ltd – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 47
Recent Developments 48
Financial Announcements 48
Nov 09, 2017: Aurobindo Pharma: Q2 FY17-18 Financial Results 48
Aug 09, 2017: Aurobindo Pharma: Consolidated Financial & Business Highlights – Q1FY18 50
Feb 09, 2017: Aurobindo Pharma Announces Q3 results & Limited Review Report for the Quarter ended December 31, 2016 51
Aug 23, 2016: Aurobindo Pharma Announces Results for the Quarter Ended June 30, 2016 52
May 30, 2016: Aurobindo Pharma: Q4 FY15-16 and FY15-16 Financial Results 53
Feb 09, 2016: Aurobindo Pharma Announces results for the quarter ended December 31, 2015 54
Corporate Communications 55
Feb 09, 2017: Aurobindo Pharma Announces Change in Board of Directors 55
Legal and Regulatory 56
Apr 19, 2017: Aurobindo Pharma Provides Update on US FDA Inspection at Bachupally Manufacturing Facility 56
Product News 57
04/26/2016: Aurobindo Pharma receives USFDA Approval for Amlodipine and Valsartan Tablets 57
03/30/2017: Aurobindo Pharma receives USFDA Approval for Generic Epzicom tablets 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Aurobindo Pharma Ltd, Deals By Therapy Area, 2011 to YTD 2017 9
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Aurobindo Pharma May Acquire Russian Business of Shreya Life Sciences 13
Intas Pharma and Aurobindo Pharma May Acquire Europen Divisions from Teva Pharma 14
Aurobindo Pharma Acquires Four Biosimilar Products from TL Biopharma 15
Arrow Generiques to Acquire Select Commercial Products in France from Teva Pharma 16
Cipla and Aurobindo Acquires Certain Generic Products Rights in the US from Teva Pharma 17
Aurobindo Pharma Completes Acquisition Of Generics Operations Of Actavis In Western Europe For US$40.8 Million 18
Aurobindo Pharma Forms Joint Venture with Tergene Biotech 20
Celon Labs Forms Joint Venture with Aurobindo Pharma 21
Aurobindo Pharma Forms Joint Venture With DIODE 22
Aurobindo Pharma, Cipla, Desano Pharma, Emcure Pharma, Hetero Labs and Laurus Labs Enter into Licensing Agreement with Medicines Patent Pool 23
Aurobindo Pharma Extends its Licensing Agreement with Medicines Patent Pool 25
Aurobindo Pharma Enters into Licensing Agreement with Medicines Patent Pool 26
Aurobindo Pharma Enters into Licensing Agreement with Medicines Patent Pool for Lopinavir/Ritonavir 27
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 28
Aurobindo Pharma Plans to Raise USD300 Million in Private Placement of Shares 30
Aurobindo Pharma Receives Board Approval for Private Placement of Shares for up to USD350 Million 31
Aurobindo Pharma Sells Manufacturing Facility In Tamilnadu 32
Aurobindo Pharma to Acquire Additional 20% Stake in Tergene Biotech 33
Agile Pharma Acquires Generis Farmaceutica from Magnum Capital Partners for USD142.8 Million 34
Eris Pharma Acquires Aurobindo Pharma Australia from Aurobindo Pharma 35
Aurobindo Pharma Acquires Natrol for USD132.5 Million 36
Aurobindo Pharma Acquires Hyacinths Pharma for up to USD3 Million 37
Aurobindo Pharma Acquires Remaining 25% Stake in Silicon Life Sciences from ABS Mercantiles 38
Aurobindo Pharma To Acquire Branded Formulations Marketing Company 39
China National Pharma Completes Acquisition Of 80.5% Interest In Aurobindo (Datong) Bio Pharma 40
Aurbindo Pharma Sells 50% Stake In Cephazone Pharma, Maker Of Cephalosporin Products 41
Aurobindo Pharma Ltd, Key Competitors 42
Aurobindo Pharma Ltd, Key Employees 43
Aurobindo Pharma Ltd, Other Locations 44
Aurobindo Pharma Ltd, Subsidiaries 44
Aurobindo Pharma Ltd, Joint Venture 47